Viatris (VTRS) Gains FDA Approval for Ryzumvi to Treat Presbyopia

gurufocus.com · 2026-10-16

On October 16, 2026, Viatris Inc (NASDAQ: VTRS) announced that its product Ryzumvi received U.S. Food and Drug Administration approval for treating presbyopia i

Read the full story at gurufocus.com →